Literary & Narrative Reviews
- Cold Wars: The Zicam Story: Hensley's 2025 book detailing the creation of Zicam has received reviews that highlight its cinematic quality.
- Critical Reception: Readers have described the narrative as a "rollercoaster ride" and a "fast-moving thriller," with many noting it would make for a compelling movie.
- Tone: It is praised for an edgy, humorous, and "unconventional" style that blends business history with personal drama.
Reviews for Charles B. Hensley's Cold Wars: The Zicam Story (published April 24, 2025) generally focus on its fast-paced, "unconventional" narrative style and its blend of biotech history with personal drama.
Key Review Themes
- Riveting Business Narrative: Reviewers frequently describe the book as a "rollercoaster ride" that captures the high-stakes world of biotech startups. It is noted for detailing the transition from academia to entrepreneurship, including investor skepticism and corporate conflicts.
- Cinematic Quality: Some readers have highlighted the story's "great movie potential," comparing its energy to a fast-moving thriller.
- Controversial & Edgy Tone: The book is praised for its "humor, chaos, and edgy behavior," offering a raw look at Hensley's life beyond scientific research—including references to a "wild" academic past.
- Insight into Innovation: Feedback emphasizes the "incredible insight" into how Zicam was developed from zinc research and launched despite heavy competition.
- Themes of Resilience: Readers resonate with the central themes of ambition and transformation, following the founders through a path of "buffoonery and eventual triumph".
Reader Ratings Summary
While specific aggregate star ratings fluctuate, the book has received 5-star feedback from early reviewers who appreciate its unique perspective on the healthcare industry. Critics and readers alike note the "clash of intellect, ambition, and rebellion" as a primary draw.
